(Q36942914)

English

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

scientific article published on October 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

rheumatoid arthritis

0 references

4

object named as

Paul Muntner

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jeffrey R Curtis

1

object named as

Jeffrey R Curtis

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Carlos G. Grijalva

5

object named as

Carlos G Grijalva

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Claire M Spettell

6

object named as

Claire Spettell

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

10

object named as

Kenneth G Saag

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Elizabeth Delzell

12

object named as

Elizabeth Delzell

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Timothy Beukelman

11

object named as

Timothy Beukelman

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Fenglong Xie

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lang Chen

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Joaquim Fernandes

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Raechele M McMahan

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

John W Baddley

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2012

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

64

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1480-1489

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Bone-density testing interval and transition to osteoporosis in older women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

29 September 2017

Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

29 September 2017

Validation of rheumatoid arthritis diagnoses in health care utilization data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

29 September 2017

Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

29 September 2017

The delivery of evidence-based preventive care for older Americans with arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

29 September 2017

Longitudinal trends in use of bone mass measurement among older americans, 1999-2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

29 September 2017

Medicare program; hospital inpatient value-based purchasing program. Final rule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

4 September 2018

Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

4 September 2018

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

4 September 2018

Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

4 September 2018

Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

4 September 2018

Racial disparities in osteoporosis prevention in a managed care population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687540

4 September 2018

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Initiation of rheumatoid arthritis treatments and the risk of serious infections

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Cardiovascular risk prediction: basic concepts, current status, and future directions

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Stratification by a multivariate confounder score

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Confounder summary scores when comparing the effects of multiple drug exposures

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Predictors of infection in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Paradoxical relations of drug treatment with mortality in older persons.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

A review of goodness of fit statistics for use in the development of logistic regression models

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Robust Locally Weighted Regression and Smoothing Scatterplots

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

A review of the healthy worker effect in occupational epidemiology

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists

1 reference

https://api.crossref.org/works/10.1002%2FACR.21805

21 January 2018

Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/22833479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of care for patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22833479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited

1 reference

https://pubmed.ncbi.nlm.nih.gov/22833479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in prevention of glucocorticoid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22833479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ACR.21805

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36942914&oldid=1823658151"